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Abstract
Objective: To describe the current knowledge and indications for use of hypertonic saline solutions
in pediatrics patients.
Sources of data: Medline recent review articles and personal files.
Summary of the findings: Basic physiologic principles were reviewed concerning the distribution of
fluid inside the intravascular, interstitial and intracellular compartments. We also reviewed the findings
concerning the mechanisms responsible for the rapid onset of cardiocirculatory effects and the additional
effect of the colloid component. Finally, we present the medical terms used in the context of small-volume
resuscitation, the indications for clinical use, the evidence from clinical research (hemorrhagic shock,
preclinical trauma care, septic shock, and head trauma), and the disadvantages and potential adverse effects
of small-volume resuscitation.
Conclusions: Resuscitation by means of hypertonic saline solutions associated or not with colloid
solutions is one of the most innovative concepts for primary resuscitation from trauma and shock
established in the past decade. Currently, the spectrum of potential indications involves not only
prehospital trauma care, but also perioperative and intensive care therapy. However, additional randomized
double-blind studies are required with both children and adult patients to confirm the advantages of the
method in terms of survival.
J Pediatr (Rio J) 2003;79(Suppl 2):S187-S94: Hypertonic saline, pediatrics, small volume, critical
care, fluid resuscitation.
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Introduction
It is more than 20 years since the first description was
published of research using resuscitation with small
volumes of hyperosmotic NaCl solution at 7.5%.1 Since
then, a large mount of work with animals2-5 and some
clinical work with humans6-9 has been published.
While the concentrations of different particles are
different across the different body fluid compartments,
osmolality (number of particles per kg of water) is
approximately the same (approximately 290 mosm/kg/
H2O) in body fluids (Figure 1). This fact is known as the
principle of isoosmolality and is the central principle in
understanding water distribution in the body.
Although intracellular and interstitial osmolality are
identical, plasma osmolality is slightly higher resulting
in important clinical implications for the choice of
resuscitation fluid. Plasma has a much higher protein
concentration than the interstitial space and these
molecules do not pass trough vascular endothelium.
A term that is used to describe a solution is its tonicity
which refers to its osmolality relative to plasma. A
solution is said to be isotonic when the normal cells of the
organism can be suspended in this environment with no
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Therefore, any mobilization of water from the intracellular
compartment, would have two important advantages: 1) a
rapid increase in plasma volume, of 3 to 4 times the infused
volume; 2) normalization of endothelial cell volume and
luminal diameter recovering small vessels, with increased
blood flow in microcirculation as a result (Figure 3).
Medical terms used in small-volume resuscitation
The term small-volume resuscitation was used by
Nakayama et al., 1984,13 in reporting on an experimental
model of hemorrhagic shock using sheep, in which there
was recovery of cardiac output and a significant increase
in systemic pressure immediately after infusion of a
hypertonic saline solution (NaCl 7.5% = 2,400 mosm/l).
Following this, a number of different clinical and
experimental studies were carried out to investigate
hypertonic solutions (NaCl, glucose, mannitol, sodium
bicarbonate, sodium acetate, saline with lactate, urea,
Tris-Cl), with variable doses, (4-6 ml/kg), differing
concentrations of sodium chloride (1.5-30% NaCl), speed
of infusion (2-15 minutes) and different administration
routes (intravenous, intraosseous). This research also
evaluated efficacy in respect of restoration of macro and
microcirculatory parameters, organ dysfunction and
survival rates.
Researchers were concerned about the resuscitation
response soon after small-volume resuscitation, when a
hypertonic saline solution is used in isolation, therefore
the saline solution (7.2-7.5%) was combined with a
colloid solution which has an elevated capacity to bond
with water (dextran 60/70 4.2-24% or hydroxyethyl
starch 60-20%), in order to preserve intravascular volume,
thus obtaining a synergic effect from the increase in
Figure 1 - Plasma osmolar concentration, interstitial and
intracellular fluid. Note that the main cation in the
plasma and in the interstitial fluid is sodium, while in
the intracellular fluid the main cation is potassium.
Adaptad from West JBE10, 1985
Figure 2 - Body fluids, causes of hypovolemia and the impact
of the infusion of hypertonic saline solution in the
mobilization of the intravascular compartment.
Adaptad from Guyton AC, 199112
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alteration in volume. This implies that the solution has
the same osmolality as plasma, and they are therefore
isoosmolar. Habitually used solutions, such as saline at
0.9% and Ringer lactate are isotonic. The sodium in
these solutions will primarily remain within the
extracellular space. Therefore, an infusion of saline at
0.9% can result in expansion of the total extracellular
space distributed so that 1/3 of the volume is in the
intravascular space and 2/3 is in the interstitial space,
resulting in no increase to extracellular osmolality nor
intracellular volume.
With the use of hypertonic saline solutions, with
concentrations of between 3.5% and 7.5%,11 there is
expansion of the extracellular space with temporary
hyperosmolality of this compartment relative to the
intracellular space. This can result in water being diverted
from the intracellular space to the extracellular space with
increased intracellular osmolality. The increase in
intracellular osmolality and the change in volume can cause
significant physiological consequences, irrespective of the
increase in hydrostatic pressure resulting from expansion of
the intravascular volume.
This therapy is based on instantaneous mobilization
of endogenous fluids across an osmotic gradient from the
intracellular space to the intravascular compartment.
The method becomes attractive because of the rapid
mobilization of endogenous water, especially from the
intracellular compartment which represents a large fluid
reserve (Figure 2).
Additionally during shock and ischemia, there is an
increase in endothelial cell volume due to lost adenosine
triphosphate (ATP) and cell membrane exchange
dysfunction, resulting in water accumulation in the cells.
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plasma osmolality with resultant mobilization of
intracellular water and increase in plasma oncotic pressure
in an attempt to conserve the volume effect.15
Consequentially, the meaning of small-volume
resuscitation or hypertonic small-volume resuscitation
changed, currently indicating primary resuscitation from
hypovolemia and shock by means of a hypertonic saline-
colloid solution (Table 1).
The advantages of small-volume resuscitation
Based on experimental data obtained in cases of traumatic
and hemorrhagic shock, it is possible to sum up the effects
of primary resuscitation with hypertonic saline solution in
isolation or in combination with hyperoncotic solutions as
being16:
– Immediate increase in systemic pressure and cardiac
output with reduced peripheral vascular resistance.
– Instantaneous increase in blood flow supply and reduced
post-ischemic reperfusion lesions.
– Improvement in organic functions as observed by
increased urinary output.
– Increased survival rates.
In addition, resuscitation with hypertonic solutions can
reduce bacterial migration in rats subjected to hemorrhagic
shock, a fact which is attributed to prevention of intestinal
hypoperfusion.17 It has been suggested that a hypertonic
saline solution such as dextran is of benefit in improving
microcirculatory disturbances post-burn and in attenuating
mesenteric lipid peroxidation and systemic oxidization
induced after burning.18
Pre-clinical use and efficacy
Current data from controlled clinical trials has shown
that the use of small-volume resuscitation is practicable and
effective compared with conventional fluid therapy for
primary resuscitation of patients with trauma,19 and also in
the emergency room.7 Research into the pre-hospital stage
of resuscitation have demonstrated favorable results in
cases of severe trauma requiring immediate surgery.8 Data
from a multicenter study9 suggest that patients with trauma
and hypotension, presenting a Glasgow coma score less
than or equal to 8 may benefit from resuscitation with an
NaCl solution at 7.5%. A revision performed by the Cochrane
Library, however, revealed that there is a problem in terms
of a lack of data proving the efficacy of hypertonic
crystalloids in reducing mortality among patients with
hypovolemia with or without head traumas.10
Figure 3 - Microcirculatory effects of hyperosmotic/
hyperoncotic solutions
HS = Hypertonic solution.
HHS = Hypertonic / Hyperosmotic solution.
d = Luminal diameter.
Table 1 - Definitions of terms used for small-volume
resuscitation
Medical term Definition
Small-volume resuscitation Primary resuscitation from
severe hypovolemia and shock
by means of infusion in bolus of
a small amount of a hypertonic
solution (about 4ml/kg)
Hypertonic small-volume Primary resuscitation from
resuscitation (or hyperosmolar hemorrhages with a small
small-volume resuscitation) amount of isolated hypertonic
solution or combined with a
colloid solution
Small-volume resuscitation Primary resuscitation from
via hypertonic-hyperoncotic hypotension due to hemorrhage
solution by means of application of a
bolus (in 2-5 minutes) of a small
volume (saline solution
combined with a hyperoncotic
colloid solution [dextran 60/70
6-10%, hydroxyethyl starch
10%])
Small-volume resuscitation Primary resuscitation from
by means of hypertonic hypovolemia and shock by
saline-colloid solution infusion in bolus (2-5 minutes)
of a small volume of a hypertonic
saline solution
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A list of potential indications for small volume
resuscitation in emergency care, during the perioperative
period and in critically ill patients can be found in Table 2.
There are a number of different solutions available
which contain hypertonic saline associated with a colloid
agent (Table 3).
Some of the combined solutions (hypertonic NaCl/
colloid) are not available in our region, but in physiological
terms the colloid adds specific beneficial effects, multiplying
the effect of the hypertonic saline solution. However, the
addition of a colloid compound can lead to an increased
incidence of side effects, such as anaphylactic reaction.
Evidence from clinical trials
Researching thermal lesions, Horton et al.,24,25
employing an experimental model using burnt pigs (45% of
body surface area burnt), employed intravenous infusion
with small volumes of saline at 7.5%/6% dextran-70 as a
supplement to standard resuscitation with Ringer lactate.
This strategy improved heart contraction performance,
reduced cardiac myocyte damage and reduced total volume
of fluids during the first 24 hours post burn. In 1973,
Monafo et al.,26 described the resuscitation of 25 children
and 81 adults with a burnt area greater than 20%, using
Table 2 - Potential indications for small volume resuscitation in emergency care
Type of alteration/shock Phase Impact
Trauma Prehospital Substitution of volume, microvascular resuscitation
Emergency room Microcirculatory resuscitation
Perioperative Substitution of volume
Head trauma Increase in intracranianal Reduction in intracranial pressure,
pressure better cerebral blood flow
Hypovolemic shock Anaphylaxis Increase in volume
Perioperative Substitution of volume (in cases of sudden bleeding)
Septic shock Hyperdinamic Substitution of volume, microcirculatory resuscitation,
increase in tissue oxygen
Hypodinamic Reopening of collapsed capillaries, microcirculatory resuscitation
Burning Initial phase Reduction in edema occurence, microcirculatory resuscitation,
reduction in bacterial translocation
Intensive care Multiorgan failure, Better blood flow and improvement of organs function,
organic failure reduction in bacterial translocation
Cardiogenic shock Stroke Replacement of volume without overload risk,
positive inotropic effect
Cardiovascular surgery Surgery Reduction in the necessity of volume, reduction in volume
allowed in a less positive fluid balance
Anesthesiology management Epidural anesthesia Generally not indicated since there are other good alternatives
Physiological replacement Generally not indicated
of volume
hypertonic saline solution at a number of different
concentrations continuously. The data indicated that
resuscitation volumes were 20 to 25% lower than those
calculated by the Parkland formula. In 1983, Bowser et
al.,27 evaluated 39 children with large areas of burns
resuscitated with hypertonic solution (17 patients), hypotonic
solution (11 patients) or colloid (11 patients). Resuscitation
with hypertonic solution resulted in lower sodium and water
losses via the burn; produced a more significant increase in
urinary volume than Ringer lactate infusion during the first
24 hours post burn; resulted in less weight gain; and had a
better cost-effectiveness ratio than resuscitation with colloid
solution. There were no statistically significant differences
between the group on hypertonic solution and colloid
solution, in respect of morbidity and mortality. These
investigations concluded that hypertonic solutions are
simple, safe and effective for acute burn management. More
recently, Murph et al.28 evaluated the systemic and
resuscitation effects and also the safety of infusions of NaCl
7.5%/6% dextran-70 solution, given as a support during
standard resuscitation with Ringer lactate after severe thermal
damage, concluded that there were no adverse side effects
related to hemodynamic or metabolic condition after infusion
of the combined solution. Early administration of the
combined solution after severe thermal lesion can reduce
cardiac dysfunction related to burning.
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The use of hyperosmotic solutions during heart surgery
was first carried out by Boldt et al.29 who demonstrated that
there were significantly lower volume requirements when a
hypertonic saline solution was used in comparison with a
standard solution of hydroxyethyl starch to correct
hypovolemia observed after extracorporeal circulation. In
order to double the level of pulmonary capillary pressure,
just 3.1 ml/kg of hypertonic saline solution were necessary
compared with a volume of 10.3 ml/kg of hydroxyethyl
starch at 6%. Later, Oliveira et al.30 used hypertonic-
hyperoncotic solution to double pulmonary capillary
pressure before extracorporeal circulation in patients who
were Jehovah’s witnesses, finding that all patients maintained
a stable metabolic and hemodynamic condition with
increased cardiac output, lower vascular resistance and a
mildly negative fluid balance. None of the patients needed
blood transfusions. Tollofsrud et al.31 infused hypertonic-
hyperoncotic solutions in 10 patients post extracorporeal
circulation and reported a reduction in fluids required to
stabilize hemodynamic status and a significantly increased
cardiac index, elevated urinary output and a post-op fluid
balance that was significantly lower. Indicators of pulmonary
function were different between the control group and the
group that received hypertonic-hyperoncotic solution,
suggesting that the excess interstitial fluid may be mobilized
by the combined solution, thus contributing to reduced
edema formation and improved tissue perfusion.
A new application for hypertonic saline solution which
is currently emerging is its use for advanced cardiac failure,
Licata et al.32 administered 150 ml of hypertonic saline
solution to 53 patients with advanced refractory heart
failure associated with a high dose of intravenous furosemide
(500-1,000 mg twice a day) and compared them with 54
patients who received the same dose of furosemide without
the hypertonic solution supplementation. The patients who
received hypertonic solution had a better hospital course
than those who did not receive it. These patients had shorter
hospital stays, less renal dysfunction, better sodium levels
on discharge and fewer adverse effects from the use of
furosemide. An editorial, by Tex D, 2003,33 makes the
comment that double-blind, randomized clinical trials are
necessary to better define the role of hypertonic solutions as
treatment for patients with advanced refractory cardiac
failure.
In 1997, Wade et al.34 performed a meta-analysis of
research in which hypertonic saline solution/dextran or
hypertonic saline solution in isolation had been used as the
primary fluid therapy for patients with traumatic lesions.
The analysis included eight studies evaluating a total of
1,170 patients. The inclusion criterion for trauma patients
was systolic arterial pressure below 100 mmHg. There were
no significant differences in 30-day survival rates when
hypertonic saline solution (7.5%) was compared with Ringer
lactate, however, there was a 5.1% increase in survival rates
when hypertonic saline solution/dextran (NaCl 7.5%/6%
dextran-70) was compared.
When the role of hypertonic solutions in septic shock
was analyzed, animal research,35 demonstrated a significant
reduction in albumin leakage, in neutrophil counts from
broncho-alveolar lavage and in the degree of
histopathological damage when compared with resuscitation
with Ringer lactate. There are few studies of humans which
have evaluated hypertonic solution in patients with sepsis.
One of these demonstrates improvements in resuscitation
parameters among clinically stable sepsis patients.36 Twenty-
none patients were included in the study and received either
Table 3 - Characteristics of products of hypertonic solutions used in the clinic practice
Product Main Content/ Osmolarity Content of sodium
substance recipient (mOsmol/l) with the infusion
of 250 ml of volume
Solution of Sodium chloride 9g/l 500 ml 309 39 mmol
NaCl 0.9%
Glucose 20% Glucose 200g/l 500 ml 1,110 None
Glucose 40% Glucose 400g/l 500 ml 2,220 None
RescueFlow NaCl 7.5%/ 250 ml 2,567 321 mmol
dextran 70 6%
HyperHAES NaCl 7.2%/ 250 ml 2,264 308 mm
hydroxyethyl starch 6%
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250 ml saline or hypertonic solution (NaCl 7.5%/8% dextran-
70). Cardiac index and systolic volume were greater in the
group that received hypertonic solution, with differences
being most apparent 1 hour after infusion.
Currently there is interest in the use of hypertonic
solutions as osmotic substances which increase intravascular
volume and combat increased intracranial pressure.37,38 In
humans hypertonic saline solutions reduce intracranial
pressure, increase intravascular volume and improve
resuscitation performance.21,39 Research carried out by
Fisher et al.,40 a randomized, controlled trial, observed
reduced intracranial pressure in 18 children with traumatic
brain damage, for a period of two hours when hypertonic
saline solution was compared with a same-volume dose of
saline. Shimma et al.41 compared the effects of Ringer
lactate and hypertonic saline on children with severe head
trauma during the first three days of the trauma, concluding
that serum sodium increases had a significant correlation
with reduced intracranial pressure and increased cerebral
perfusion pressure. Hypertonic saline solution has also
been used with other conditions associated with increased
intracranial pressure, as in work by Suarez et al.,42 who
evaluated the effects of administering 23.4% saline
intravenously for refractory hypertension intracranial with
eight patients with a number of different intracranial
conditions, concluding that hypertonic solution reduces
intracranial pressure and significantly improves cerebral
perfusion pressure. Another study by the same group of
authors,38 describes the evolution of cerebral edema and
intracranial pressure in a heterogeneous group of critically
ill patients who were treated with a hypertonic solution of
NaCl/acetate 3%. The infusion was maintained at a velocity
of 75-150ml/hour until the patients demonstrated clinical
improvement, developed complications or there was a
failure to respond after sodium levels had reached 135-155
mmol/L. Reductions were also observed in average
intracranial pressure during the first 12 hours among head
trauma patients and those with edema in post-op, but the
same effect was not observed among the patients with non-
traumatic intracranial hemorrhage or cerebral infarction.
A small retrospective study performed by Peterson et
al.43 evaluated 68 children with head trauma with whom
hypertonic solution of NaCl at 3% was used with the
objective of reducing intracranial pressure to < 20 mmHg.
The treatment effectively reduced intracranial pressure in
these patients, and only three deaths were observed (4%)
due to uncontrolled intracranial pressure. The graph for one
patient, analyzed in isolation, is presented in Figure 4.
Another prospective study, by Kanna et al.,44 evaluated
the effect of prolonged infusion of NaCl solution at 3% with
10 pediatric patients with traumatic brain damage and
refractory hypertension intracranial despite conventional
treatments.
Hypertonic solution of NaCl works by increasing sodium
and serum osmolality, creating an osmotic gradient which
transfers water from the intracellular compartment of the
brain to the interstitial, thus reducing cerebral edema and
intracranial pressure. While mannitol has a similar action,
sodium chloride has a more favorable reflection coefficient
(1.0) than does mannitol (0.9), making hypertonic solutions
ideal agents when these effects are desired. Hypertonic
solution can also normalize the resting membrane potential
and cell volume, restoring the intracellular electrolyte
balance of damaged cells, suggesting that this treatment
could have preferential benefits in damaged areas of the
brain.45
Disadvantages and potential adverse effects
The infusion in bolus of a hypertonic NaCl solution to
a peripheral vein at a concentration above 10% causes
significant hemolysis while solutions at 7-7.5% are reported
to be safe. Although the concept of resuscitation with
hypertonic solutions involves a considerable increase in
osmolar charge, work carried out to date does not report any
acute clinical signs of hyperosmolality. Serum osmolality
reduces after the first 4-8 hours of infusion and, after 24
hours there is no difference between patients who have
received hypertonic saline solution and controls.20,46
There may also be electrolyte disturbances, primarily
related to the sodium. Neuropathological signs of continuous
central myelinolysis were not found in any of the patients
that died. Chlorine levels also increase and may be associated
with acidosis (hyperchloremic acidosis).
The addition of a crystalloid solution is also not immune
to risks, primarily anaphylactic reactions. However, none
of the controlled clinical trials attributed adverse effects to
the colloid component.34
Figure 4 - Serum sodium and intracranial pressure curves
according to time in a patient. Note the inverse
relation between serum sodium and intracranial
pressure, which was statistically significant in all
patients (p < 0.05)
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Hyperosmolar coma
Hypernatremia
Hypopotassemia
Seizures
Arrhythmia
Negative inotropic effect (after rapid infusion)
Tissue necrosis (in cases of extravasation)
Hemoyisis (in the puncture site)
Increase in bleeding (in non-controlled hemorrhage)
Anaphylaxis (related to colloid component)
Table 4 - Potential side effects associated with small-volume
resuscitation
Potential side effects associated with small-volume
resuscitation are shown in Table 4.
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Other effects of hypertonic solutions
Some physiological alterations associated with
hypertonic fluids include alterations to the cytotoxicity of
leukocytes,47 pulmonary of neutrophils sequestration,35
neutrophils activation48 and alterations to vascular
permeability induced by endotoxins.49
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